In PICP-treated tumors the concurrent low expression of RECK and high expression of MMP-9, and the induction in tumor cells expression of MT1-MMP and MMP-2 will push up the balance of proteolysis compared to control. This evidence concerns the gene MMP9 and neoplasm.